(Sr.) Director, Portfolio Strategy & Management at Tempus

Chicago, Illinois, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Biotechnology, Oncology, Precision MedicineIndustries

Requirements

Bachelor's degree required, MBA preferred
8+ years of experience in an analytical business role such as business strategy, finance, sales operations, and/or business intelligence
2+ years of experience in commercial strategy / sales operations
3+ years of experience managing direct reports
Strong business acumen, including the ability to translate data insights into action plans
Excellent verbal and written communication skills
Entrepreneurial mindset and comfort with ambiguity
Solutions-oriented and biased to action
Commercial experience in oncology, with clinician-facing products, and/or within a life sciences company

Responsibilities

Develop near and long-term portfolio vision, strategy and roadmap for Tempus’ oncology products, based on analysis of customer needs, competitive landscape, internal feasibility, and financial and strategic value (deliverables include 3-5 year long term franchise plans, near-term franchise plans, target product profiles, commercialization and lifecycle management plans)
Collaborate with cross-functional leadership (sales, marketing, market access, medical, product, R&D, customer success, etc.) to deliver on business goals for the oncology portfolio
Ensure appropriate resource availability and prioritization
Constantly evaluate trade-off decisions to ensure product development speed, efficiency, and quality
Develop launch clinical evidence and reimbursement strategies to guide new product launch planning
Proactively monitor competitive intelligence and customer feedback to identify and act on new threats and opportunities
Manage business prioritization, facilitate the development of objectives and key results (OKRs), manage product forecasts and execution of business objectives
Evaluate new business partnership opportunities to deliver new offerings to customers or open new channels to sell
Oversee the implementation of new partnerships, foster strong relationships and manage performance of the partnership
Develop short, medium and long term strategies for business growth across the end to end customer experience
Manage product launch strategy, coordinate launch across the commercial organization
Support the creation and execution plan to achieve the long term strategy, working closely with the Senior Director, Genomics, and articulate that vision internally and externally to align the organization to that plan
Evaluate and refine the list of initiatives based on experimentation and customer feedback
Manage six direct reports (leads of individual testing portfolios, customer experience and partnership management/product launch)

Skills

Portfolio Strategy

Genomics

Oncology

Strategic Planning

Competitive Analysis

Product Roadmap

Commercialization

Lifecycle Management

Cross-Functional Collaboration

Market Access

Reimbursement Strategies

Revenue Targeting

WGS

Assay Development

Tempus

AI-driven healthcare data analysis platform

About Tempus

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Chicago, IllinoisHeadquarters

2015Year Founded

$894.9MTotal Funding

IPOCompany Stage

AI & Machine Learning, Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Relocation Assistance

Company Equity

Performance Bonus

Risks

Competition from partners like Genialis may lead to conflicts of interest.

Ambry Genetics acquisition could pose financial risks if synergies aren't realized.

Technical challenges may arise in integration with Flatiron's OncoEMR platform.

Differentiation

Tempus uses AI to analyze clinical and molecular data for precision medicine.

Their platform aids in personalized treatment decisions for cancer patients.

Tempus collaborates with biotech firms to enhance drug development using real-world data.

Upsides

Increased AI adoption in healthcare boosts Tempus' partnerships and collaborations.

Acquisition of Ambry Genetics expands Tempus' genetic testing capabilities.

Integration with Flatiron's OncoEMR enhances precision in cancer treatment plans.

Land your dream remote job 3x faster with AI

Try Jobo Free